Piclidenoson for Treatment of COVID-19

Clinical trial NCT04333472 · COMPLETED

Trial details

NCT number: NCT04333472
Sponsor: Can-Fite BioPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Coronavirus Infection

Start date: 2021-01-06
Primary completion: 2022-03-06
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.